Rho pull-down assay

BY Bo Yin
DL Dan-Dong Li
SX Shang-Yu Xu
HH Huan Huang
JL Jian Lin
HS Han-Song Sheng
JF Jun-Hao Fang
JS Jin-Ning Song
MZ Ming Zhang
ask Ask a question
Favorite

The RhoA activity was determined using a rhotekin Rho-binding domain (RBD) affinity precipitation assay, followed by immunoblotting using a RhoA antibody. Active RhoA was affinity purified with GST bead-bound Rhotekin, which only binds RhoA in its active GTP-bound form. Then, Western blot analysis was performed to detect both active levels and total levels using a RhoA-specific antibody. A NewEast Biosciences RhoA Activation Assay Kit (Malvern, PA, USA) was used to detect the levels. Briefly, ice-cold lysis buffer (25 mmol/L HEPES, pH 7.5, 150 mmol/L NaCl, 1% Igepal CA-630, 10 mmol/L MgCl2, 1 mmol/L EDTA, 10% glycerol, 1 Ag/mL aprotinin, 10 Ag/mL leupeptin, and 1 mmol/L Na3VO4) was added to brain homogenate (2:1 v:v), and incubated on ice for 30 mins. The lysates were centrifuged for 10 mins (12,000×g at 4°C). Lysates were incubated with agarose-conjugated rhotekin-RBD for 1 hr at 4°C and were then washed three times using lysis buffer. Agarose beads were boiled in SDS-PAGE sample buffer to release active Rho, and samples were resolved on a 12.5% polyacrylamide gel followed by immunoblotting using a RhoA antibody.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A